Latest news with #TELUSHealth
Yahoo
24-05-2025
- Business
- Yahoo
The Smartest Blue-Chip Stock to Buy With $3,500 Right Now
Written by Amy Legate-Wolfe at The Motley Fool Canada When the market feels uncertain, it's tempting to sit on the sidelines and wait for things to settle down. But often, the smartest investors are the ones who lean in, especially when it comes to blue-chip stocks offering long-term value. For Canadians looking to invest $3,500 right now, TELUS (TSX:T) stands out as one of the smartest choices on the TSX. With a reliable dividend, strong growth in healthcare and tech, and a customer-first strategy, this is a stock built for long-term success. TELUS isn't just another telecom. Yes, it provides wireless and internet services to millions of Canadians, but its business has expanded far beyond cell phones and fibre. The company strategically invested in digital healthcare and technology solutions, creating new growth streams that add value well beyond traditional telecom margins. That diversification paid off, especially as demand for virtual care and digital connectivity has continued to rise. In its most recent earnings report for Q1 2025, TELUS reported consolidated revenue of $5.1 billion, up 3% from the same period last year. Adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) climbed 4% year over year to $1.7 billion, showing that TELUS is growing not just the top line but also the profitability of its business. Net income attributable to common shareholders was $365 million, or $0.25 per share. The company added 218,000 new customer connections during the quarter, including 39,000 new mobile phones and 29,000 new internet subscribers. These are strong numbers in a competitive industry where growth is often slow and incremental. What really makes TELUS different from other telecoms is its investment in TELUS Health and TELUS International. TELUS Health now services millions of Canadians with virtual care, digital pharmacy, and health data platforms. In Q1 2025, this segment grew its revenue by 12% and adjusted EBITDA by 30%. That's substantial growth in a part of the business that didn't even exist a decade ago. It gives TELUS a foothold in one of the world's fastest-growing sectors, while still generating cash from its traditional infrastructure backbone. TELUS International, which provides a digital customer experience and artificial intelligence (AI) solutions for businesses around the world, continues to scale as well. While still a smaller contributor to total revenue, it helps position TELUS as a forward-looking company that's aligned with digital trends. Another major reason to like TELUS is its dividend. As of today, the stock yields around 7.5%, with a quarterly payout of $0.3636 per share. TELUS has raised its dividend 23 times since 2011, and management recently confirmed they intend to grow it by 3% to 8% annually through at least 2028. And with a payout ratio under 75% of free cash flow, it's a dividend that looks sustainable. TELUS also invests heavily in its infrastructure, which keeps customers loyal and future-proofs the business. In 2024, it committed over $3.5 billion to capital expenditures, expanding 5G coverage and fibre networks across Canada. That might seem like a lot, but in telecom, staying ahead in speed and service matters. TELUS has consistently ranked high in customer satisfaction, and its churn rate remains one of the lowest in the industry. That means customers stick around, which supports stable revenue and margin growth over time. From a valuation standpoint, TELUS looks attractive. The stock is down from its highs, trading at about $22 per share as of writing. That gives investors a chance to buy into a high-quality company at a reasonable price. Its forward price-to-earnings ratio is at 28, while its long-term earnings growth is supported by its expanding business segments and strong free cash flow. For Canadians thinking about where to park $3,500 for growth and income, TELUS offers a rare combination. It's stable, diversified, and innovative, with a track record of delivering shareholder returns. Whether you're investing through a TFSA or RRSP, this is the kind of stock that pays you to be patient. While others debate the direction of the market, TELUS quietly connects homes, supports doctors, and builds digital solutions, turning your investment into long-term value. The post The Smartest Blue-Chip Stock to Buy With $3,500 Right Now appeared first on The Motley Fool Canada. Before you buy stock in Telus, consider this: The Motley Fool Stock Advisor Canada analyst team just identified what they believe are the Top Stocks for 2025 and Beyond for investors to buy now… and Telus wasn't one of them. The Top Stocks that made the cut could potentially produce monster returns in the coming years. Consider MercadoLibre, which we first recommended on January 8, 2014 ... if you invested $1,000 in the 'eBay of Latin America' at the time of our recommendation, you'd have $21,345.77!* Stock Advisor Canada provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month – one from Canada and one from the U.S. The Stock Advisor Canada service has outperformed the return of S&P/TSX Composite Index by 24 percentage points since 2013*. See the Top Stocks * Returns as of 4/21/25 More reading Made in Canada: 5 Homegrown Stocks Ready for the 'Buy Local' Revolution [PREMIUM PICKS] Market Volatility Toolkit Best Canadian Stocks to Buy in 2025 Beginner Investors: 4 Top Canadian Stocks to Buy for 2025 5 Years From Now, You'll Probably Wish You Grabbed These Stocks Subscribe to Motley Fool Canada on YouTube Fool contributor Amy Legate-Wolfe has no position in any of the stocks mentioned. The Motley Fool recommends TELUS. The Motley Fool has a disclosure policy. 2025 Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
20-05-2025
- Business
- Yahoo
New Report: TELUS Health's inaugural Pharmacy Trends market analysis unveils Canadian pharmacies poised for $1.9B tech-driven transformation
Specialty pharmacy market expected to exceed $20B with over 10,000 licensed pharmacies filling critical healthcare gaps nationwide Advanced pharmacy systems enabling seamless collaboration and digital technology putting prescription management at patients' fingertips TORONTO, May 20, 2025 /CNW/ - Canada's pharmacy sector is undergoing a revolution to meet changing healthcare needs, according to TELUS Health's inaugural Pharmacy Trends Report: The Future of Pharmacy in Canada: Five Trends Shaping Canada's Healthcare Landscape in 2025. With the automated central fill pharmacy market projected to reach $1.9 billion by 2030 and Canada's specialty pharmacy market expected to exceed $20 billion, technological automation is enabling pharmacists to step into expanded healthcare roles, fundamentally changing how people in Canada access primary care services. "We're witnessing a seismic shift in Canadian healthcare delivery," said Ratcho Batchvarov, Vice-president, Provider Solutions, TELUS Health. "Our first Pharmacy Trends report reveals that pharmacies are rapidly evolving into comprehensive healthcare hubs, bridging critical gaps in primary care access. With the specialty pharmacy market set to surge beyond $20 billion and automation driving a $1.9 billion revolution in central fill services, we're not just talking about incremental change – this is a fundamental reimagining of community healthcare. Pharmacists have been advancing their role as frontline care providers, leveraging cutting-edge technology to offer more accessible, efficient and personalized care. This transformation is creating a more resilient and responsive healthcare ecosystem for all Canadians." The Pharmacy Trends Report provides valuable insights on how the Canadian pharmacy sector is evolving, enabling both pharmacists and pharmacy managers to identify opportunities for improved efficiencies in their practice and enhance patient care. Three notable trends from this first report include: Putting an expanded scope of practice into action: As millions of people in Canada struggle to find a family doctor, the nation's network of more than 10,000 licensed pharmacies is stepping up to fill critical healthcare gaps. These locations offer essential medical services, from vaccinations to prescribing medications for minor ailments. Patients see their pharmacists 1.5 to 10 times more than they see their primary care physician. Enhancing collaboration and streamlining operations: technology solutions can empower pharmacists to deliver their services in a way that's comfortable to them, and patients can access consistent services and care, regardless of where they go: Centralized prescription fulfillment reduces errors and administrative burdens, allowing pharmacists to focus on patient care. Over a quarter of community pharmacists in one survey noted their dissatisfaction with the daily volume of prescriptions to be processed. Advanced Pharmacy Management Systems allow pharmacists to collaborate seamlessly with other healthcare providers, ensuring patients receive consistent, well-coordinated care across all touchpoints. Specialty drug claims have tripled over the past 15 years, rising from 10.4 per cent to 32.8 per cent of total pharmacy claims. This dramatic increase means pharmacists must now manage more complex medication regimens while ensuring patients receive proper guidance and care. Engaging the patient: patients are taking control of their healthcare through digital technology. Modern pharmacy apps put prescription management at their fingertips, while allowing them to securely track their health data. This digital connection helps pharmacists spot health trends earlier and deliver more personalized care when patients need it most. "A recent survey found that 82 per cent of people in Canada reported being interested in virtual care appointments, showing yet again how patients are looking for more control of their healthcare journey," explained Batchvarov. "Embracing this type of patient engagement, while providing a platform that keeps personal medical information confidential with the highest data security protocols, is a key way forward in securing the trust of patients." The newly released 2025 Pharmacy Trends Report sparked valuable discussion at the company's recent Annual Conference in Toronto on April 29, 2025 — a key forum that brought together leaders from the healthcare, pharmacy, insurance and benefits sectors. This year's conference explored a comprehensive approach to connected healthcare, encompassing the pharmacy, physician and public health sectors, while reaffirming our dedication to data-informed and technology-driven solutions for Canada's healthcare ecosystem. About TELUS HealthTELUS Health is on a mission to become the most trusted wellbeing company in the world by enhancing the overall efficiency of healthcare and championing workplace wellbeing. By integrating advanced healthcare technology with comprehensive employee support services, TELUS Health provides a holistic approach to primary and preventive health and wellbeing enhancing more than 150 million lives across more than 200 countries and territories. Our innovative digital health platforms, including electronic medical records (EMRs) and virtual care solutions, empower healthcare professionals, employers and governments to deliver personalized care efficiently. Our employee wellbeing programs empower individuals by offering extensive support through Employee and Family Assistance Programs (EFAPs), mental health resources, financial counselling and workplace wellness initiatives. At TELUS Health, we are committed to revolutionizing healthcare to ensure people receive the support they need and employees thrive both personally and professionally. Together, let's make the future friendly. For more information please visit: For media inquiries, please contact:Marielle HossackTELUS SOURCE TELUS Health View original content to download multimedia:
Cision Canada
20-05-2025
- Business
- Cision Canada
New Report: TELUS Health's inaugural Pharmacy Trends market analysis unveils Canadian pharmacies poised for $1.9B tech-driven transformation Français
Specialty pharmacy market expected to exceed $20B with over 10,000 licensed pharmacies filling critical healthcare gaps nationwide Advanced pharmacy systems enabling seamless collaboration and digital technology putting prescription management at patients' fingertips TORONTO, May 20, 2025 /CNW/ - Canada's pharmacy sector is undergoing a revolution to meet changing healthcare needs, according to TELUS Health's inaugural Pharmacy Trends Report: The Future of Pharmacy in Canada: Five Trends Shaping Canada's Healthcare Landscape in 2025. With the automated central fill pharmacy market projected to reach $1.9 billion by 2030 and Canada's specialty pharmacy market expected to exceed $20 billion, technological automation is enabling pharmacists to step into expanded healthcare roles, fundamentally changing how people in Canada access primary care services. View PDF "We're witnessing a seismic shift in Canadian healthcare delivery," said Ratcho Batchvarov, Vice-president, Provider Solutions, TELUS Health. "Our first Pharmacy Trends report reveals that pharmacies are rapidly evolving into comprehensive healthcare hubs, bridging critical gaps in primary care access. With the specialty pharmacy market set to surge beyond $20 billion and automation driving a $1.9 billion revolution in central fill services, we're not just talking about incremental change – this is a fundamental reimagining of community healthcare. Pharmacists have been advancing their role as frontline care providers, leveraging cutting-edge technology to offer more accessible, efficient and personalized care. This transformation is creating a more resilient and responsive healthcare ecosystem for all Canadians." The Pharmacy Trends Report provides valuable insights on how the Canadian pharmacy sector is evolving, enabling both pharmacists and pharmacy managers to identify opportunities for improved efficiencies in their practice and enhance patient care. Three notable trends from this first report include: Putting an expanded scope of practice into action: As millions of people in Canada struggle to find a family doctor, the nation's network of more than 10,000 licensed pharmacies is stepping up to fill critical healthcare gaps. These locations offer essential medical services, from vaccinations to prescribing medications for minor ailments. Patients see their pharmacists 1.5 to 10 times more than they see their primary care physician. Enhancing collaboration and streamlining operations: technology solutions can empower pharmacists to deliver their services in a way that's comfortable to them, and patients can access consistent services and care, regardless of where they go: Centralized prescription fulfillment reduces errors and administrative burdens, allowing pharmacists to focus on patient care. Over a quarter of community pharmacists in one survey noted their dissatisfaction with the daily volume of prescriptions to be processed. Advanced Pharmacy Management Systems allow pharmacists to collaborate seamlessly with other healthcare providers, ensuring patients receive consistent, well-coordinated care across all touchpoints. Specialty drug claims have tripled over the past 15 years, rising from 10.4 per cent to 32.8 per cent of total pharmacy claims. This dramatic increase means pharmacists must now manage more complex medication regimens while ensuring patients receive proper guidance and care. Engaging the patient: patients are taking control of their healthcare through digital technology. Modern pharmacy apps put prescription management at their fingertips, while allowing them to securely track their health data. This digital connection helps pharmacists spot health trends earlier and deliver more personalized care when patients need it most. " A recent survey found that 82 per cent of people in Canada reported being interested in virtual care appointments, showing yet again how patients are looking for more control of their healthcare journey," explained Batchvarov. "Embracing this type of patient engagement, while providing a platform that keeps personal medical information confidential with the highest data security protocols, is a key way forward in securing the trust of patients." The newly released 2025 Pharmacy Trends Report sparked valuable discussion at the company's recent Annual Conference in Toronto on April 29, 2025 — a key forum that brought together leaders from the healthcare, pharmacy, insurance and benefits sectors. This year's conference explored a comprehensive approach to connected healthcare, encompassing the pharmacy, physician and public health sectors, while reaffirming our dedication to data-informed and technology-driven solutions for Canada's healthcare ecosystem. About TELUS Health TELUS Health is on a mission to become the most trusted wellbeing company in the world by enhancing the overall efficiency of healthcare and championing workplace wellbeing. By integrating advanced healthcare technology with comprehensive employee support services, TELUS Health provides a holistic approach to primary and preventive health and wellbeing enhancing more than 150 million lives across more than 200 countries and territories. Our innovative digital health platforms, including electronic medical records (EMRs) and virtual care solutions, empower healthcare professionals, employers and governments to deliver personalized care efficiently. Our employee wellbeing programs empower individuals by offering extensive support through Employee and Family Assistance Programs (EFAPs), mental health resources, financial counselling and workplace wellness initiatives. At TELUS Health, we are committed to revolutionizing healthcare to ensure people receive the support they need and employees thrive both personally and professionally. Together, let's make the future friendly. For more information please visit: For media inquiries, please contact: Marielle Hossack TELUS Health [email protected]
Yahoo
15-05-2025
- Business
- Yahoo
TELUS' Workplace Options Buyout to Boost its Share in Digital Health
In a major move to strengthen its position in the global health and well-being sector, TELUS Corporation TU has partnered with GTCR, a prominent private equity firm with deep expertise in healthcare, to support TELUS Health's acquisition of Workplace Options. This acquisition, valued at approximately C$500 million ($350 million) in cash, excluding about C$100 million ($70 million) in assumed debt, marks a pivotal step in TELUS Health's journey to become a global leader in digital-first wellness solutions. Workplace Options, a well-established provider of integrated employee wellbeing services, operates in more than 200 countries and territories, and has a strong portfolio of innovative and scalable offerings. TELUS Corporation price-consensus-chart | TELUS Corporation Quote The deal significantly boosts TELUS Health's international footprint and capabilities, enabling the company to serve more than 150 million lives worldwide. With a growing demand for holistic, technology-driven health solutions, TELUS Health is uniquely positioned to meet the evolving needs of individuals and organizations across various industries and regions. This acquisition not only enhances TELUS Health's service capacity but also reinforces its commitment to empowering individuals to live healthier lives through comprehensive, accessible digital health and wellbeing solutions. With the backing of GTCR and the integration of Workplace Options' global network, TELUS Health is set to redefine the standard of care in the global employee wellbeing market. As part of the Workplace Options acquisition, GTCR will invest $200 million, leveraging its deep industry expertise and history of successful corporate transaction brings significant benefits to TELUS Health, firmly establishing it as a global leader in employer health and well-being services. With a network of over 180,000 providers across more than 200 countries and territories, the company now has unmatched global reach. The deal also enables TELUS Health to deliver a standardized and scalable model for Employee and Family Assistance Programs (EFAP) and well-being solutions, supported by its industry-leading customer service and expansive global presence. By integrating TELUS' robust infrastructure and network capabilities with Workplace Options' advanced digital solutions and TELUS Digital's AI expertise, the company gains a powerful competitive edge in the international market. Momentum in Health Services bodes well. In the first quarter of 2025, TELUS Health's operating revenues and other income revenues increased 12% year over year to C$473 million, driven by strong health services revenues. TELUS has also acquired LifeWorks to expand its presence in the digital health services market, and Competence Call Center to broaden its portfolio of customer experience, digital transformation and other services. With the LifeWorks acquisition, TELUS is looking at enhancing TELUS Health product offerings to international clients through synergies with TELUS International. TELUS Health's adjusted EBITDA grew 30% year over year in the first quarter, driven by revenue growth, cost reductions and acquisition synergies. TELUS currently carries a Zacks Rank #3 (Hold). Shares of the company have lost 5.9% in the past year compared with the Zacks Diversified Communication Services industry's decline of 7.1%. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. Image Source: Zacks Investment Research Some better-ranked stocks from the broader utilities space are Fortis Inc. FTS, Atmos Energy Corporation ATO and Exelon Corporation EXC. FTS carries a Zacks Rank #1 (Strong Buy), while ATO and EXC carry a Zacks Rank #2 (Buy). Fortis' earnings beat the Zacks Consensus Estimate in each of the trailing four quarters, with the average surprise being 3.58%. In the last reported quarter, FTS delivered an earnings surprise of 1.45%. The company's long-term earnings growth rate is 5%. Its shares have gained 13.9% in the past year. Atmos Energy's earnings beat the Zacks Consensus Estimate in each of the trailing four quarters, with the average surprise being 2.59%. In the last reported quarter, ATO delivered an earnings surprise of 3.77%. The company's long-term earnings growth rate is 7.2%. Its shares have gained 28.4% in the past year. Exelon Corporation's earnings beat the Zacks Consensus Estimate in each of the trailing four quarters, with the average surprise being 10.05%. In the last reported quarter, EXC delivered an earnings surprise of 8.24%. EXC's long-term earnings growth rate is 6.4%. Its shares have increased 9.4% in the past year. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Exelon Corporation (EXC) : Free Stock Analysis Report TELUS Corporation (TU) : Free Stock Analysis Report Atmos Energy Corporation (ATO) : Free Stock Analysis Report Fortis (FTS) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
14-05-2025
- Business
- Yahoo
WindRose Health Investors Completes the Sale of Workplace Options to TELUS Health
NEW YORK, May 14, 2025 /PRNewswire/ -- WindRose Health Investors, LLC ("WindRose"), the New York-based healthcare private equity firm, announced that it has completed the sale of Workplace Options, LLC ("WPO" or the "Company") to TELUS Health, a business within TELUS Corporation, a leading global communications, data and technology company, in a transaction valued at approximately $425 million. WPO is a leading global provider of integrated employee wellbeing solutions, supporting more than 88 million people across 127,000 organizations in more than 200 countries and territories. WindRose completed a majority recapitalization of WPO in October 2021. "We are proud to have partnered with the WPO management team to support their global growth and platform development," said David Pontius, Partner at WindRose. "Over the past few years, the Company strengthened its global presence and deepened its capabilities as a trusted provider to employers and employees worldwide. We're excited to see how the combination with TELUS Health will further accelerate WPO's impact on global employee wellbeing." The Company delivers a highly differentiated suite of comprehensive health and wellbeing services through a combination of digital innovation, a global provider network, and a high-touch service model. WPO's scale, reach, and reputation for service excellence have established it as a trusted partner to both resellers and multinational employers. "WindRose has been a valued partner to WPO, and we are grateful for their commitment as we expanded our reach and invested in our technology, infrastructure, and service delivery," said Alan King, President and CEO of WPO. "We look forward to this next chapter with TELUS Health as we unite in our shared mission of scaling care, connection, and innovation in workplace wellbeing." McDermott Will & Emery acted as legal advisor to WindRose, and Houlihan Lokey acted as financial advisor. About Workplace OptionsWorkplace Options is a leading global provider of integrated employee wellbeing solutions. Through customized programs, and a comprehensive global network of credentialed providers and professionals, WPO supports individuals to become healthier, happier, and more productive both personally and professionally. WPO delivers high-quality care digitally and in-person to more than 88 million people across 127,000 organizations in more than 200 countries and territories. For more information, please visit About WindRose Health InvestorsWindRose makes equity investments in companies that operate within the services sectors of the healthcare industry. The firm focuses on companies with profitable business models and a demonstrated ability to deliver cost-effective solutions. WindRose manages over $3.6 billion. WindRose is based in New York City and invests in companies throughout the United States. For more information, please email us at info@ Contact:Lambert by LLYCCaroline Luzcluz@ View original content: SOURCE WindRose Health Investors Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
